Unlocking the Potential of miRNA-Targeted Therapies
Fill out the form below and we'll send your colleague an invitation to the "Unlocking the Potential of miRNA-Targeted Therapies" event.
Interest in oligonucleotide therapeutics is growing, with several drugs already approved and many more in development, offering a promising avenue for targeted therapies. However, oligonucleotide therapies targeting microRNA (miRNA) are yet to be successful.
In this webinar, our expert speaker will explore the therapeutic potential of miRNA- targeting treatments, outlining cutting-edge research that is identifying new miRNA targets.
He’ll also discuss the latest methodologies in miRNA research, including next-generation sequencing and miRNA inhibition.
- Explore a brief history of oligonucleotide therapeutics, from routine failure to routine success
- Learn why oligonucleotide therapeutics targeting miRNAs have not been successful
- Discover how nuclear RNA interference offers a new approach to identifying therapeutic target miRNAs